前房内注射莫西沙星所致毒性眼前节综合征：病例报告及文献复习
Toxic Anterior Segment Syndrome with Intracameral Moxifloxacin: Case Report and Review of the Literature.
作者信息
Amireskandari Annahita, Bean Andrew, Mauger Thomas
机构信息
Department of Ophthalmology and Visual Sciences, West Virginia University, Morgantown, WV, USA.
出版信息
Case Rep Ophthalmol Med. 2021 Mar 2;2021:5526097. doi: 10.1155/2021/5526097. eCollection 2021.
Abstract
A case of severe anterior segment toxicity secondary to high-volume, undiluted intracameral moxifloxacin for endophthalmitis prophylaxis is reported. We examine the other reported cases of toxicity after intracameral moxifloxacin, as well as iris depigmentation and transillumination syndromes after oral and topical fluoroquinolone exposure. Additionally, we review the literature on safety, efficacy, and appropriate dosing of intracameral antibiotics with a focus on moxifloxacin.
摘要
报告了1例因使用高容量、未稀释的前房内莫西沙星预防眼内炎而继发严重眼前节毒性的病例。我们研究了其他已报道的前房内注射莫西沙星后出现毒性的病例，以及口服和局部使用氟喹诺酮类药物后出现的虹膜色素脱失和透照综合征。此外，我们回顾了关于前房内抗生素安全性、有效性和适当剂量的文献，重点是莫西沙星。
相似文献
1
Toxic Anterior Segment Syndrome with Intracameral Moxifloxacin: Case Report and Review of the Literature.
Case Rep Ophthalmol Med. 2021 Mar 2;2021:5526097. doi: 10.1155/2021/5526097. eCollection 2021.
2
Unilateral acute iris depigmentation and transillumination after glaucoma surgery with mitomycin application and intracameral moxifloxacin.
Am J Ophthalmol Case Rep. 2020 Feb 27;18:100639. doi: 10.1016/j.ajoc.2020.100639. eCollection 2020 Jun.
3
Unilateral Acute Iris Transillumination Syndrome following Uneventful Phacoemulsification Surgery with Intracameral Moxifloxacin.
Ocul Immunol Inflamm. 2022 Oct-Nov;30(7-8):1984-1987. doi: 10.1080/09273948.2021.1916042. Epub 2021 May 18.
4
Safety of undiluted intracameral moxifloxacin without postoperative topical antibiotics in cataract surgery.
Int Ophthalmol. 2016 Aug;36(4):493-8. doi: 10.1007/s10792-015-0151-x. Epub 2015 Nov 14.
5
Intracameral moxifloxacin for endophthalmitis prophylaxis after cataract surgery: Cost-effectiveness analysis.
J Cataract Refract Surg. 2018 Aug;44(8):971-978. doi: 10.1016/j.jcrs.2018.05.022. Epub 2018 Jul 23.
6
Unilateral acute iris transillumination like syndrome following intracameral moxifloxacin injection.
Ocul Immunol Inflamm. 2022 Feb 17;30(2):318-319. doi: 10.1080/09273948.2020.1817495. Epub 2020 Sep 25.
7
Efficacy and safety of prophylactic intracameral moxifloxacin injection in Japan.
J Cataract Refract Surg. 2013 Nov;39(11):1702-6. doi: 10.1016/j.jcrs.2013.05.036. Epub 2013 Sep 18.
8
Cost-effectiveness analysis of intracameral cefuroxime use for prophylaxis of endophthalmitis after cataract surgery.
Ophthalmology. 2009 Oct;116(10):1887-96.e1. doi: 10.1016/j.ophtha.2009.03.014. Epub 2009 Jun 28.
9
Moxifloxacin and bilateral acute iris transillumination.
J Ophthalmic Inflamm Infect. 2013 Jan 14;3(1):10. doi: 10.1186/1869-5760-3-10.
10
Prophylactic intracameral cefazolin and postoperative topical moxifloxacin after cataract surgery: endophthalmitis risk reduction and safety results in a 16-year study.
Graefes Arch Clin Exp Ophthalmol. 2019 Oct;257(10):2185-2191. doi: 10.1007/s00417-019-04417-9. Epub 2019 Aug 7.
引用本文的文献
1
Efficacy and safety of prophylactic simultaneous intravitreal moxifloxacin injection with standard intravitreal anti-VEGF injection procedure in cases of cystoid macular edema and macular neovascularization.
BMC Ophthalmol. 2025 May 22;25(1):306. doi: 10.1186/s12886-025-04124-6.
2
Toxic Anterior Segment Syndrome: A 2012-2022 Update on the Most Common Causes.
J Cataract Refract Surg. 2025 Jan 21;51(4):323-31. doi: 10.1097/j.jcrs.0000000000001610.
3
Presumed atypical late-onset toxic anterior segment syndrome after implantable collamer lens implantation: a case report.
BMC Ophthalmol. 2024 Aug 15;24(1):347. doi: 10.1186/s12886-024-03615-2.
4
Toxic anterior segment syndrome (TASS): A review and update.
Indian J Ophthalmol. 2024 Jan 1;72(1):11-18. doi: 10.4103/IJO.IJO_1796_23. Epub 2023 Dec 22.
5
Frosted branch angiitis following corneal tear repair.
Taiwan J Ophthalmol. 2022 Feb 14;12(4):491-494. doi: 10.4103/tjo.tjo_52_21. eCollection 2022 Oct-Dec.
本文引用的文献
1
Unilateral acute iris transillumination like syndrome following intracameral moxifloxacin injection.
Ocul Immunol Inflamm. 2022 Feb 17;30(2):318-319. doi: 10.1080/09273948.2020.1817495. Epub 2020 Sep 25.
2
Anterior Uveitis Due to Intracameral Moxifloxacin: A Case Report.
Ocul Immunol Inflamm. 2021 Nov 17;29(7-8):1366-1369. doi: 10.1080/09273948.2020.1757120. Epub 2020 May 29.
3
Unilateral acute iris depigmentation and transillumination after glaucoma surgery with mitomycin application and intracameral moxifloxacin.
Am J Ophthalmol Case Rep. 2020 Feb 27;18:100639. doi: 10.1016/j.ajoc.2020.100639. eCollection 2020 Jun.
4
Comparative corneal endothelial cell toxicity of differing intracameral moxifloxacin doses after phacoemulsification.
J Cataract Refract Surg. 2020 Mar;46(3):355-359. doi: 10.1097/j.jcrs.0000000000000064.
5
Quinolone antibiotics.
Medchemcomm. 2019 Jun 28;10(10):1719-1739. doi: 10.1039/c9md00120d. eCollection 2019 Oct 1.
6
Aqueous level abatement profiles of intracameral antibiotics: A comparative mathematical model of moxifloxacin, cefuroxime, and vancomycin with determination of relative efficacies.
J Cataract Refract Surg. 2019 Nov;45(11):1568-1574. doi: 10.1016/j.jcrs.2019.06.009.
7
Injection volume and intracameral moxifloxacin dose.
J Cataract Refract Surg. 2019 Oct;45(10):1498-1502. doi: 10.1016/j.jcrs.2019.04.020. Epub 2019 Aug 20.
8
Bilateral acute iris transillumination (BAIT) syndrome: literature review.
Clin Ophthalmol. 2019 Jun 5;13:935-943. doi: 10.2147/OPTH.S167449. eCollection 2019.
9
Acute depigmentation of the iris: a retrospective analysis of 22 cases.
Can J Ophthalmol. 2019 Feb;54(1):33-39. doi: 10.1016/j.jcjo.2018.03.020. Epub 2018 May 21.
10
Safety and efficacy of intracameral moxifloxacin for prevention of post-cataract endophthalmitis: Randomized controlled clinical trial.
J Cataract Refract Surg. 2019 Mar;45(3):343-350. doi: 10.1016/j.jcrs.2018.10.044. Epub 2019 Jan 25.
Zotero 插件